Johnson & Johnson Archives - Vista Partners LLC

The Year of the Bispecific: Biotech’s Double-Edged Breakout -( $ARKG $IBB $XBI $RHBBY $AMGN $JNJ )

by Vista Partners LLC December 10, 2025 105Views 0Likes

If 2024 crowned weight-loss drugs the belle of the healthcare ball, 2025 belongs to the bispecific antibody. What began as a niche in immuno-oncology has evolved into biotech’s most competitive—and potentially lucrative—battleground, drawing fresh capital, dealmaking, and analyst optimism that borders on…

S&P 500, Nasdaq Rally as Rate‑Cut Bets Lift -Nov. 24, 2025 -( $AAPL $AVGO $GOOG $INTC $LLY $META $NOK $OPEN $SOAR $TSLA Rise!)

by Vista Partners LLC November 24, 2025 3151Views 0Likes

Wall Street shook off its November sulk on Monday, with the major benchmarks staging a rate-cut–hope rally that looked suspiciously like early Christmas cheer delivered by central bankers rather than Santa. The S&P 500 climbed about 1.55% to roughly 6,705.12, the Dow…

From Lilly’s Defensiveness to Tesla’s Turbulence: Winners and Laggards in a Volatile Week for Wall Street -( $DV $EXAS $INTG $JNJ $LLY $MCD $SOAR $VIX Rise!)

by Vista Partners LLC November 21, 2025 3175Views 0Likes

Large caps took a hit this week with the Dow 30 ending at 46,245.41, -1.9% & the S&P 500 closed at 6,602.99 equally off 1.9%. The high-beta tech kept the Nasdaq on the defensive for most of the week and fell 2.7%…

Wall Street Sputters on AI Jitters: Nasdaq Slide, Walmart Exceeds, & Exact Sciences’ $23B Buyout Lead Market Moves – Nov. 20,2025 -( $EPRX $EXAS $MENS $MTWO $PACS $VIX $WMT Rise!)

by Vista Partners LLC November 20, 2025 3055Views 0Likes

In the end, Thursday looked like a market attempting to renegotiate its relationship with AI, tariffs and the Fed all at once—discovering, not for the first time, that even in an age of algorithms and GLP‑1s, gravity still has a vote. Indexes…

Nvidia’s Blockbuster AI Beat Lifts Wall Street: Stock Market Recap – November 19, 2025 -( $AAPL $EXAS $GOOG $NVDA $OKLO $SER $TSLA $TSM $VIX Rise!)

by Vista Partners LLC November 19, 2025 2736Views 0Likes

U.S. stocks closed Wednesday looking more contemplative than chaotic, as Wall Street tiptoed into the bell ahead of Nvidia’s after-hours earnings—and then promptly exhaled when the AI titan delivered another blockbuster beat. The S&P 500 and Nasdaq finished modestly higher after shaking…

Wall Street Shuffled Its Fearful Feet As Volatility Popped On Tuesday, Nov. 18, 2025 -( $JAZZ $MTWO $ONDS $SOAR $SRRK $VIX Rise!)

by Vista Partners LLC November 18, 2025 2546Views 0Likes

Wall Street shuffled its fearful feet on Tuesday, November 18, 2025, as investors digested a buffet of macroeconomic reports, corporate news, and political drama—the kind of day that makes even seasoned traders wish for a stronger coffee and perhaps, a bar of…

Wall Street Indices Slide as Investors Await Nvidia Earnings – Nov. 17, 2025 -( $EPRX $GOOG $INTG $JAZZ $JNJ $PACS $VIX Rise!)

by Vista Partners LLC November 18, 2025 2432Views 0Likes

Monday was a classic "hold your horses" day, with Wall Street digesting fresh economic data, tariff news, and awaiting Nvidia’s AI-focused earnings report later this week. Stock indices retreated modestly but maintain strong YTD performance, investors eyeing the yield curve and FOMC…

Modular Medical Gains IRB Green Light for Next-Gen Tubeless Insulin Delivery Device -( $MODD )

by Vista Partners LLC November 17, 2025 357Views 0Likes

Modular Medical (NASDAQ: MODD) is injecting fresh ambition into the world of diabetes care, touting Institutional Review Board (IRB) approval to deliver insulin with its Pivot™ tubeless patch pump to adult study participants just as the company pursues FDA clearance for commercial…

J&J’s $3 Billion Bet: Halda’s Cancer Tech Joins the Pharma Powerball Acquisition Parade -( $JNJ $RNA $NVS $AZN $DIA)

by Vista Partners LLC November 17, 2025 276Views 0Likes

Johnson & Johnson (JNJ) made headlines with its definitive agreement to acquire Halda Therapeutics, a privately head clinical-stage biotech company famed for its Regulated Induced Proximity Targeting Chimera (RIPTAC) platform, in a $3.05 billion cash deal. The strategic move, set to strengthen…

U.S.-Based GeoVax Emerges as Key Monopoly Challenger Amid $2.99B Bavarian Nordic Takeover – ($GOVX $IBB $XBI)

by John F. Heerdink, Jr. July 31, 2025 178Views 0Likes

Bavarian Nordic, a leading Danish vaccine manufacturer best known for its MVA-BN (Modified Vaccinia Ankara–Bavarian Nordic) smallpox and mpox vaccines, recently agreed to a $2.99 billion takeover by private equity firms Permira and Nordic Capital. Shareholders are being offered 233 Danish kroner…

Johnson & Johnson

Your Guide To Staying Informed In The Markets